These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 212736)

  • 61. The relative effectiveness of guanidinium and some biguanide salts as denaturants. Assessment against penicillinase.
    Mitchinson C; Pain RH; Vinson JR; Walker T
    Biochim Biophys Acta; 1983 Feb; 743(1):31-6. PubMed ID: 6600627
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC; Ostergaard BE
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Post antibiotic, post beta-lactamase inhibitor and post antibiotic sub-MIC effect of ceftriaxone/tazobactam on beta-lactamase-producing Escherichia coli in vitro].
    Zhang SC; Zhang LL; Chen SW; Wu HY; Liu XK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1071-4. PubMed ID: 20067122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.
    Dale JW
    Biochem J; 1971 Jul; 123(4):501-5. PubMed ID: 4942447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.
    Peterson LR
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():181-4. PubMed ID: 18154544
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
    Dudley MN
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S23-8. PubMed ID: 7606586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kinetics and mechanism of beta-lactamase inhibition by phosphonamidates: the quest for a proton.
    Rahil J; Pratt RF
    Biochemistry; 1993 Oct; 32(40):10763-72. PubMed ID: 8399224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The inactivation of Bacillus cereus 569/H bera-lactamase by 6-beta-(trifluoromethane-sulfonyl)amidopenicillanic acid sulfone: pH dependence and stoichiometry.
    Mezes PS; Clarke AJ; Dmitrienko GI; Viswanatha T
    J Antibiot (Tokyo); 1982 Jul; 35(7):918-20. PubMed ID: 6294040
    [No Abstract]   [Full Text] [Related]  

  • 69. Chromosome-encoded beta-lactamases of Citrobacter diversus. Interaction with beta-iodopenicillanate and labelling of the active site.
    Amicosante G; Oratore A; Joris B; Galleni M; Frère JM; Van Beeumen J
    Biochem J; 1988 Sep; 254(3):891-3. PubMed ID: 2848500
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FR-900318, a novel penicillin with beta-lactamase inhibitory activity.
    Yamashita M; Hashimoto S; Ezaki M; Iwami M; Komori T; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1774-6. PubMed ID: 6319348
    [No Abstract]   [Full Text] [Related]  

  • 71. Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.
    Frère JM; Dormans C; Duyckaerts C; De Graeve J
    Biochem J; 1982 Dec; 207(3):437-44. PubMed ID: 6299270
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Degradation of beta-lactamase inhibitor, (2S,3R,5S)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thi a-1- azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide (YTR-830H), in aqueous solutions and alkaline methanol solution: pathway and structural elucidation of products.
    Marunaka T; Matsushima E; Minami Y; Yoshida K; Azuma R
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4478-87. PubMed ID: 2854499
    [No Abstract]   [Full Text] [Related]  

  • 73. 6 beta-Halopenicillanic acids, a group of beta-lactamase inhibitors.
    von Daehne W
    J Antibiot (Tokyo); 1980 Apr; 33(4):451-2. PubMed ID: 6251019
    [No Abstract]   [Full Text] [Related]  

  • 74. The crystal structure of beta-lactamase from Staphylococcus aureus at 0.5 nm resolution.
    Moult J; Sawyer L; Herzberg O; Jones CL; Coulson AF; Green DW; Harding MM; Ambler RP
    Biochem J; 1985 Jan; 225(1):167-76. PubMed ID: 2983660
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis of deuterium- and tritium-labeled 6 beta-bromopenicillanic acid.
    Claes PJ; Vanderhaeghe H; Roets E; Thomis J; De Meester F; Piette JL
    J Antibiot (Tokyo); 1985 Jan; 38(1):75-82. PubMed ID: 2982779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unexpected influence of ionic strength on branched-pathway interactions between beta-lactamases and beta-halogenopenicillanates.
    De Meester F; Matagne A; Dive G; Frère JM
    Biochem J; 1989 Jan; 257(1):245-9. PubMed ID: 2537624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nature of the inhibition of some cephalosporinases by carbenicillin].
    Labia R; Fabre C
    Biochim Biophys Acta; 1976 Nov; 452(1):209-18. PubMed ID: 990312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies on penicillinase inhibitors produced by microorganisms.
    Hata T; Omura S; Iwai Y; Ono H; Takeshima H
    J Antibiot (Tokyo); 1972 Aug; 25(8):473-4. PubMed ID: 4648490
    [No Abstract]   [Full Text] [Related]  

  • 79. Benzyl 6-oxopenicillanate and derivatives. II.
    Sheehan JC; Lo YS
    J Org Chem; 1973 Sep; 38(18):3227-8. PubMed ID: 4354848
    [No Abstract]   [Full Text] [Related]  

  • 80. Diketene analogs as beta-lactamase inhibitor.
    Tanizawa K; Santoh K; Kanaoka Y
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):824-5. PubMed ID: 2787706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.